At a glance
ClinicalIndex Comparison RecordN/ACompleted· 72 enrolled
Drug / intervention
HairMax LaserComb +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind Clinical Trial to Evaluate the Safety and Efficacy of the HairMax LaserComb 2009, 9 Beam Model: For the Treatment of Androgenetic Alopecia in Females
In Brief
A clinical study evaluating HairMax LaserComb and Control Device for Androgenetic Alopecia and 2 related conditions. Completed, enrolled 72 participants across 5 sites.
Detailed Summary
The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 9 beam model in promoting hair growth in females diagnosed with androgenetic alopecia when treatment is applied as directed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAndrogenetic Alopecia, Hair Loss, Female Pattern Baldness
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2009
Enrollment StartOct 2009
Primary CompletionOct 2010
TodayJul 2026
First PostedSep 22, 2009
Enrollment StartOct 1, 2009
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 16.8 years ago
Interventions
HairMax LaserCombdevice
Device application 3 times week, for 26 weeks
Control Devicedevice
Device application 3 times week, for 26 weeks